Literature DB >> 19660537

Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.

Noemi Csaba1, Magnus Köping-Höggård, Maria Jose Alonso.   

Abstract

Ionically crosslinked nanoparticles based on high and low molecular weight chitosans (CS) were formulated with plasmid DNA or dsDNA oligomers using the ionic gelation technique with pentasodium tripolyphospate (TPP) as crosslinking agent. The resulting CS/TPP nanoparticles were investigated with regard to their physical-chemical properties, in vitro transfection efficiency, toxicity, cellular uptake, and in vivo gene expression following intratracheal administration to mice. The effects of co-formulating the nanoparticles with a model protein, BSA, were also studied. CS/TPP nanoparticles showed high encapsulation efficiencies both for plasmid DNA and dsDNA oligomers (20-mers), independent of CS molecular weight. TEM images revealed a spherical shape of the CS/TPP nanoparticles in contrast to the heterogeneous and irregular morphology displayed by conventional chitosan polyplexes. The nanoparticles showed high physical stability and no DNA release could be detected in diverse release media, nor even after incubation with heparin. Low molecular weight (LMW) CS/TPP nanoparticles gave high gene expression levels in HEK 293 cells already 2 days after transfection, reaching a plateau of sustained and high gene expression between 4 and 10 days. The inclusion of BSA into the nanostructures did not alter the inherent transfection efficiency of the nanoparticles. Confocal studies suggest endocytotic cellular uptake of the nanoparticles and a subsequent release into the cytoplasm within 14 h. LMW CS/TPP nanoparticles mediated a strong beta-galactosidase expression in vivo after intratracheal administration. The results of this study forward ionically crosslinked CS/TPP nanoparticles as a biocompatible non-viral gene delivery system and generate a solid ground for further optimization studies, for example with regard to steric stabilization and targeting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660537     DOI: 10.1016/j.ijpharm.2009.07.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  28 in total

1.  Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

Review 2.  Micro- and nanoparticulates for DNA vaccine delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-04

3.  Preparation of NGF encapsulated chitosan nanoparticles and its evaluation on neuronal differentiation potentiality of canine mesenchymal stem cells.

Authors:  Bhabesh Mili; Kinsuk Das; Ajay Kumar; A C Saxena; Praveen Singh; Srikanta Ghosh; Sadhan Bag
Journal:  J Mater Sci Mater Med       Date:  2017-12-04       Impact factor: 3.896

4.  Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery.

Authors:  Manuela Raviña; Eva Cubillo; David Olmeda; Ramón Novoa-Carballal; Eduardo Fernandez-Megia; Ricardo Riguera; Alejandro Sánchez; Amparo Cano; María José Alonso
Journal:  Pharm Res       Date:  2010-09-21       Impact factor: 4.200

5.  Reversible Swelling of Chitosan and Quaternary Ammonium Modified Chitosan Brush Layers: Effect of pH and Counter Anion Size and Functionality.

Authors:  Hyun-Su Lee; Michael Q Yee; Yonaton Y Eckmann; Noreen J Hickok; David M Eckmann; Russell J Composto
Journal:  J Mater Chem       Date:  2012-10-07

6.  Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation.

Authors:  Nitin Mali; Preeti Wavikar; Pradeep Vavia
Journal:  AAPS PharmSciTech       Date:  2014-08-30       Impact factor: 3.246

7.  Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Authors:  Chompoonuch Sawaengsak; Yasuko Mori; Koichi Yamanishi; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  AAPS PharmSciTech       Date:  2013-12-17       Impact factor: 3.246

Review 8.  Polysaccharide-based nanoparticles for theranostic nanomedicine.

Authors:  M Swierczewska; H S Han; K Kim; J H Park; S Lee
Journal:  Adv Drug Deliv Rev       Date:  2015-11-27       Impact factor: 15.470

9.  Dense chitosan surgical membranes produced by a coincident compression-dehydration process.

Authors:  Thomas P Dooley; April L Ellis; Maria Belousova; Don Petersen; Arthur A DeCarlo
Journal:  J Biomater Sci Polym Ed       Date:  2012-08-13       Impact factor: 3.517

10.  Stability and bioactivity of chitosan as a transfection agent in primary human cell cultures: A case for chitosan-only controls.

Authors:  Tanya L Cupino; Billy A Watson; Alan C Cupino; Keiji Oda; Mark G Ghamsary; Salvador Soriano; Wolff M Kirsch
Journal:  Carbohydr Polym       Date:  2017-10-06       Impact factor: 9.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.